{"id":"https://openalex.org/A5126355359","orcid":"https://orcid.org/0009-0005-0101-1064","observed_orcids":["https://orcid.org/0009-0005-0101-1064"],"display_name":"Pallvi Kumari","raw_author_names":["Pallvi  Kumari","Pallvi Kumari"],"full_name":"Pallvi Kumari","works_count":13,"cited_by_count":22,"summary_stats":{"2yr_mean_citedness":1.6923076923076923,"h_index":3,"i10_index":1},"ids":{"openalex":"https://openalex.org/A5126355359","orcid":"https://orcid.org/0009-0005-0101-1064","observed_orcids":["https://orcid.org/0009-0005-0101-1064"]},"affiliations":[{"institution":{"id":"https://openalex.org/I4405258160","ror":"https://ror.org/007czgh25","display_name":"CT University","country_code":"IN","type":"education","lineage":["https://openalex.org/I4210094618","https://openalex.org/I4405258160"]},"years":[2026]}],"last_known_institutions":[{"id":"https://openalex.org/I4405258160","ror":"https://ror.org/007czgh25","display_name":"CT University","country_code":"IN","type":"education","lineage":["https://openalex.org/I4210094618","https://openalex.org/I4405258160"]}],"topics":[{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","count":5,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T14099","display_name":"Synthesis and Characterization of Heterocyclic Compounds","count":3,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","count":2,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","count":2,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","count":2,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"topic_share":[{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","value":3.37e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","value":1.69e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13023","display_name":"Synthesis of Organic Compounds","value":1.6e-05,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","value":1.55e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T14099","display_name":"Synthesis and Characterization of Heterocyclic Compounds","value":1.48e-05,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"x_concepts":[{"id":"185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","score":0.9785450100898743},{"id":"71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","score":0.7268999814987183},{"id":"2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","score":0.6837999820709229},{"id":"74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","score":0.5382999777793884},{"id":"21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","score":0.49045655131340027}],"counts_by_year":[{"year":2025,"works_count":1,"oa_works_count":0,"cited_by_count":1},{"year":2026,"works_count":12,"oa_works_count":3,"cited_by_count":21}],"display_name_alternatives":["Pallvi  Kumari","Pallvi Kumari"],"block_key":"p kumari","works_api_url":"https://api.openalex.org/works?filter=author.id:A5126355359","awards_count":0,"updated_date":"2026-11-04T11:47:51","created_date":"2025-04-02T00:00:00"}